New Triple-Threat vaccine aims to shield seniors from three winter viruses
⭐️ VACCINE ⭐️
Ongoing
This study tests two new vaccines (SCB-1022 and SCB-1033) designed to protect against RSV, human metapneumovirus, and parainfluenza virus. Researchers will enroll 612 healthy adults aged 60-85 to check safety and immune response. The goal is to see if combining protection against…
Phase: PHASE1, PHASE2 • Sponsor: Clover Biopharmaceuticals AUS Pty • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 09:21 UTC